Skip to main content

Hallucinogens and Related Drugs

  • Chapter
Drug and Alcohol Abuse

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 120 Accesses

Abstract

Both marijuana and the hallucinogens produce a change in the level of consciousness, and both are capable of inducing hallucinations. However, in the usual doses taken, the predominant effect of cannabis is to alter the “feeling state” with less intensity and without frank hallucinations. The drugs discussed in this chapter produce more intense changes and often yield abnormal sensory inputs of a predominantly visual nature (illusions or hallucinations), even at low doses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jaffe, J. H. Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, T. W. Rall, und F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York, Macmillan, 1985, pp. 532–581.

    Google Scholar 

  2. Leonard, H. L., und Rapoport, J. L. Treatment of anorexia nervosa patient with fluoxetine. American Journal of Psychiatry 144: 1239–1240, 1987.

    PubMed  CAS  Google Scholar 

  3. Hollister, L. E. Clinical aspects of use of phenylalkylamine and indolealkylamine hallucinogens. Psychopharmacology 22: 977–979, 1986.

    Google Scholar 

  4. Dorrance, D. L., Janiger, O., und Teplitz, R. L. Effect of peyote on human chromosomes: Cytogenetic study of the Huichol Indians of Northern Mexico. Journal of the American Medical Association 234: 299–302, 1975.

    Article  PubMed  CAS  Google Scholar 

  5. Dobkin de Rios, M. Man, culture and hallucinogens: An overview. In V. Rubin (Ed.), Cannabis and Culture. The Hague: Mouton, 1975, pp. 76–92.

    Google Scholar 

  6. Hofmann, F. G., und Hofmann, A. D. A Handbook on Drug and Alcohol Abuse. New York: Oxford University Press, 1975.

    Google Scholar 

  7. White, F. J., und Appel, J. B. Lysergic acid diethylamide (LSD) and lisuride: Differentiation of their neuropharmacological actions. Science 216: 535–537, 1982.

    Article  PubMed  CAS  Google Scholar 

  8. Jacobs, B. L., und Trulson, M. E. Mechanisms of action of LSD. American Scientist 67: 396–404, 1979.

    PubMed  CAS  Google Scholar 

  9. Weaver, K. E. C. LSD and schizophrenia. Archives of General Psychiatry 41:631, 1984.

    Google Scholar 

  10. Jacobs, B. L. Effects of classical hallucinogenic drugs are mediated by an action at postsynaptic serotonergic sites. Paper presented at the American College of Neuropsychopharmacology Annual Meeting, Maui, Hawaii, December 10, 1985.

    Google Scholar 

  11. Vardy, M. M., und Kay, S. R. LSD psychosis or LSD-induced schizophrenia? Archives of General Psychiatry 40: 877–883, 1983.

    Article  PubMed  CAS  Google Scholar 

  12. Segal, D. S., und Schuckit, M. A. Animal models of stimulant-induced psychosis. In I. Creese (Ed.), Stimulants: Neurochemical, Behavioral and Clinical Perspectives. New York: Raven Press, 1982, pp. 131–168.

    Google Scholar 

  13. Cohen, S. The hallucinogens. Drug Abuse and Alcoholism Newsletter 13, July 1984.

    Google Scholar 

  14. Diagnosis and management of reactions to drug abuse. Medical Letter 19:13–16,1977.

    Google Scholar 

  15. Ungerleider, J. T., und Frank, I. M. Emergency treatment of adverse reactions to hallucinogenic drugs. In P. G. Bourne (Ed.). A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Govemment Printing Office, 1974, pp. 73–76.

    Google Scholar 

  16. Davis, M., Kehne, J. H., Commissaris, R. L., und Geyer, M. A. Effects of hallucinogens on unconditioned behaviors in animals. In B. L. Jacobs (Ed.), Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives. New York, Raven Press, 1984, pp. 35–75.

    Google Scholar 

  17. Schlemmer, R. F., Nawara, C., Heinze, W. J., et al Influence of environmental context on tolerance to LSD-induced behavior in primates. Biological Psychiatry 21: 314–317, 1986.

    Article  PubMed  CAS  Google Scholar 

  18. Cohen, S. (Ed.). Pharmacology of drugs of abuse. Drug Abuse and Alcoholism Newsletter 5: 1–4, 1976.

    Google Scholar 

  19. Brown, J. K., und Malone, M. H. Some U.S. street drug identification programs. Journal of the American Pharmaceutical Association 13: 670–675, 1973.

    PubMed  CAS  Google Scholar 

  20. Bowers, M. B., Jr. Psychoses precipitated by psychotomimetic drugs: A follow-up study. Archives of General Psychiatry 34: 832–835, 1977.

    Article  PubMed  Google Scholar 

  21. Editorial: Epidemiology of drug usage. Lancet 1: 147–148, 1985.

    Google Scholar 

  22. Smart, R. G., Adlaf, E. M., und Goodstadt, M. S. Alcohol and other drug use among Ontario students: An update. Canadian Journal of Public Health 77: 57–58, 1986.

    CAS  Google Scholar 

  23. Editorial: National survey finds continuing decline in use of illicit drugs by high school seniors. Hospital and Community Psychiatry 36: 1011, 1985.

    Google Scholar 

  24. Blackford, L. Student Drug Surveys-San Mateo County, California, 1968–1975. San Mateo, California: San Mateo County Department of Public Health and Welfare, 1975.

    Google Scholar 

  25. Shapira, J., und Cherubin, C. E. Drug Abuse: A Guide for the Clinician. New York: American Elsevier, 1975.

    Google Scholar 

  26. Taylor, R. L., Maurer, J. I., und Tinklenberg, J. R. Management of “bad trips” in an evolving drug scene. Journal of the American Medical Association 213: 422–425, 1970.

    Article  PubMed  CAS  Google Scholar 

  27. Frosch, W. A., Robbins, E. S., und Stern, M. Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. New England Journal of Medicine 273:1235–1239, 1965.

    Google Scholar 

  28. Levy, R. M. Diazepam for LSD intoxication. Lancet 1: 1297, 1971.

    Article  PubMed  CAS  Google Scholar 

  29. Goodwin, D. W., und Guze, S. B. Psychiatric Diagnosis ( 4th ed. ). New York: Oxford University Press, 1988.

    Google Scholar 

  30. Cohen, S. (Ed.). Flashbacks. Drug Abuse and Alcoholism Newsletter 6: 1–3, 1977.

    Google Scholar 

  31. Yager, J., Crumpton, E., und Rubenstein, R. Flashbacks among soldiers discharged as unfit who abused more than one drug. American Journal of Psychiatry 140: 857–861, 1983.

    PubMed  CAS  Google Scholar 

  32. Forrest, J. A. H., und Tarala, R. A. 60 hospital admissions due to reactions to lysergide (LSD). Lancet 2: 1310–1313, 1973.

    Article  PubMed  CAS  Google Scholar 

  33. Winek, C. L., Collom, W. D., und Bricker, J. D. A death due to 4-bromo-2,5-dimethoxyamphetamine. Clinical Toxicology 18: 261–266, 1981.

    Article  PubMed  CAS  Google Scholar 

  34. Shoichet, R. Emergency treatment of acute adverse reactions to hallucinogenic drugs. In P. G. Bourne (Ed.). A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 80–82.

    Google Scholar 

  35. Abruzzi, W. Drug-induced psychosis. International Journal of the Addictions 12:183–193, 1977.

    Google Scholar 

  36. Friedman, S. A., und Hirsh, S. E. Extreme hyperthermia after LSD ingestion. Journal of the American Medical Association 217:1549–1550, 1971.

    Google Scholar 

  37. Lake, C. R., Stirba, A. L., Kinneman, R. E. et al. Mania associated with LSD ingestion. American Journal of Psychiatry 138: 1508–1509, 1981.

    PubMed  CAS  Google Scholar 

  38. Liskow, B. LSD and prolonged psychotic reactions. American Journal of Psychiatry 128:1154, 1972.

    Google Scholar 

  39. Glass, G. S., und Bowers, M. B. Chronic psychosis associated with long-term psychotomimetic drug abuse. Archives of General Psychiatry 23: 97–102, 1970.

    Article  PubMed  CAS  Google Scholar 

  40. Ungerleider, J. T. LSD and the courts. American Journal of Psychiatry 126 (8):1179,1970.

    Google Scholar 

  41. Goldstein, J. A. Niacin and acute psychedelic psychosis. Biological Psychiatry 19: 272–273, 1984.

    PubMed  CAS  Google Scholar 

  42. Grant, I., Mohns, L., Miller, M., und Reitan, R. M. A neuropsychological study of polydrug users. Archives of General Psychiatry 33: 973–978, 1976.

    Article  PubMed  CAS  Google Scholar 

  43. Abraham, H. D. A chronic impairment of colour vision in users of LSD. British Journal of Psychiatry 140: 518–520, 1982.

    Article  PubMed  CAS  Google Scholar 

  44. Culver, C. M., und King, F. W. Neuropsychological assessment of undergraduate marihuana and LSD users. Archives of General Psychiatry 31: 707–711, 1974.

    Article  PubMed  CAS  Google Scholar 

  45. Smith, C. G., und Asch, R. H. Drug abuse and reproduction. Fertility and Sterility 48: 355–373, 1987.

    PubMed  CAS  Google Scholar 

  46. Emanuel, I., und Ansell, J. S. LSD, intrauterine amputations, and amniotic-band syndrome. Lancet 2: 158–159, 1971.

    Google Scholar 

  47. Bloom, A. D. Peyote (mescaline) and human chromosomes. Journal of the American Medical Association 234: 313, 1975.

    Article  PubMed  CAS  Google Scholar 

  48. Ricuarte, G., Bryan, G., und Strauss, L. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229: 986–988, 1985.

    Article  Google Scholar 

  49. Bowen, J. S., Davis, G. B., Kearney, T. E., und Bardin, J. Diffuse vascular spasm associated with 4bromo-2,5-dimethoxyamphetamine ingestion. Journal of the American Medical Association 249:1477–1479, 1983.

    Google Scholar 

  50. Dietz, W. H., Jr., und Stuart, M. J. Nutmeg and prostaglandins. New England Journal of Medicine 294: 503, 1976.

    PubMed  Google Scholar 

  51. Schulze, R. G. Nutmeg as a hallucinogen. New England Journal of Medicine 295: 174, 1976.

    PubMed  CAS  Google Scholar 

  52. Faguet, R. A., und Rowland, K. F. “Spice cabinet” intoxication. American Journal of Psychiatry 135: 860–861, 1973.

    Google Scholar 

  53. Fink, P. J., Goldman, M. J., und Lyons, I. Morning glory seed psychosis. Archives of General Psychiatry 15: 209–213, 1966.

    Article  Google Scholar 

  54. Domino, E. F. The hallucinogens. In R. W. Richter (Ed.). Medical Aspects of Drug Abuse. New York: Harper und Row, 1975, pp. 210–217.

    Google Scholar 

  55. Molyneux, R. J. Loco intoxication: Indolizidine alkaloids of spotted locoweed (Astragalus lentiginosus). Science 216: 190–191, 1982.

    Article  PubMed  CAS  Google Scholar 

  56. Lane, G. A. Nitrous oxide is fetotoxic. Science 210: 889–890, 1980.

    Article  Google Scholar 

  57. Block, S. H. The grocery store high. American Journal of Psychiatry 135: 126, 1978.

    PubMed  CAS  Google Scholar 

  58. Gillman, M. A. Safety of nitrous oxide. Lancet 2: 1397, 1982.

    Article  PubMed  CAS  Google Scholar 

  59. Goode, E., und Troiden, R. R. Amyl nitrite use among homosexual men. American Journal of Psychiatry 136: 1067–1069, 1979.

    PubMed  CAS  Google Scholar 

  60. McManus, T. F. Amyl nitrite. Lancet 1: 503, 1982.

    Article  PubMed  CAS  Google Scholar 

  61. Lange, W. R., Haertzen, C. A., Hickey, I. E., et al Nitrite inhalants: Patterns of abuse in Baltimore and Washington, D.C. American Journal of Drug and Alcohol Abuse 14: 29–39, 1988.

    Article  PubMed  CAS  Google Scholar 

  62. Mirvish, S. S., und Haverkos, H. W. Butyl nitrite in the induction of Kaposi’s sarcoma in AIDS. New England Journal of Medicine 317: 1603, 1987.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schuckit, M.A. (1989). Hallucinogens and Related Drugs. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0767-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0767-0_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0769-4

  • Online ISBN: 978-1-4757-0767-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics